BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 193833)

  • 1. Cyclic AMP metabolism in cholesterol-rich platelets.
    Sinha AK; Shattil SJ; Colman RW
    J Biol Chem; 1977 May; 252(10):3310-4. PubMed ID: 193833
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
    Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
    Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action of vitamin E on platelet function.
    Steiner M; Mower R
    Ann N Y Acad Sci; 1982; 393():289-99. PubMed ID: 6293365
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets.
    Nogimori K; Kajikawa N; Nishio S; Yajima M
    Prostaglandins; 1989 Feb; 37(2):205-12. PubMed ID: 2543034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotides and aggregation in platelets of spontaneously hypertensive rats.
    Hamet P; Fraysse J; Franks DJ
    Circ Res; 1978 Oct; 43(4):583-91. PubMed ID: 210976
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
    Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
    J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
    Macfarlane DE; Mills DC; Srivastava PC
    Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
    Best LC; Martin TJ; Russell RG; Preston FE
    Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
    [No Abstract]   [Full Text] [Related]  

  • 11. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils.
    Lad PM; Goldberg BJ; Smiley PA; Olson CV
    Biochim Biophys Acta; 1985 Aug; 846(2):286-95. PubMed ID: 2411298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of prostaglandin E1 binding to human blood platelet membrane by insulin and the activation of adenylate cyclase.
    Kahn NN; Sinha AK
    J Biol Chem; 1990 Mar; 265(9):4976-81. PubMed ID: 1969414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of human platelet adenylate cyclase by prostacyclin (PGX).
    Gorman RR; Bunting S; Miller OV
    Prostaglandins; 1977 Mar; 13(3):377-88. PubMed ID: 191876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1989 Aug; 984(1):113-8. PubMed ID: 2548620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate.
    Beretz A; Briançon-Scheid F; Stierlé A; Corre G; Anton R; Cazenave JP
    Biochem Pharmacol; 1986 Jan; 35(2):257-62. PubMed ID: 3002388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do human platelets have opiate receptors?
    Reches A; Eldor A; Vogel Z; Salomon Y
    Nature; 1980 Nov; 288(5789):382-3. PubMed ID: 6253832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
    Hidaka H; Asano T
    J Biol Chem; 1976 Dec; 251(23):7508-16. PubMed ID: 187590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-dependent proteolytic stimulation of adenylate cyclase in platelets from spontaneously hypertensive rats.
    Tremblay J; Hamet P
    Metabolism; 1984 Aug; 33(8):689-95. PubMed ID: 6087083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of S-(1,2-dicarboxyethyl)glutathione on collagen-induced platelet aggregation; enhancements of cyclic AMP level and adenylate cyclase activity in platelets by S-(1,2-dicarboxyethyl)glutathione.
    Tsuboi S; Fujiwara E; Ogata K; Sakaue A; Nakayama T; Ohmori S
    Biol Pharm Bull; 1993 Nov; 16(11):1083-6. PubMed ID: 8312859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.